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The influence of SermionR on cellular protein synthesis in the 
mouse brain was studied in vivo, after an intraperitoneal administr-
ation of 50 microgram doses. The brain samples analyzed at different 
intervals after drug treatment showed a short-term increase of 
3H-Leucine incorporation into proteins, followed by a. gradual 
decline of uptake. The latter reached control levels about 18 h 
after drug administration. Under similar experimental treatments 
Sermion had no effect on the synthesis of RNA catalyzed by Mg++-
-ions; however, a slight stimulation of the Mn++- activated RNA 
synthesis was obserwed. 
Mice receiving i. p. injections of 50 micrograms of Sermion 
showed an increased brain rnethyltransferase activity; the maximum 
stimulation was observed one hour after drug treatment. In another 
set of experiments the capacity of mouse brain preparations to 
catalyze the methyl group incorporation into the exogenously added 
transfer RNA (tRNA) was found to decrease with increasing age of 
the animals; the addition of 10-4 M Sermion to the incubation me-
dium enhanced endogenous rnethylation, especially in the older 
animals. On the other hand the capacity to methylate the exogeno-
usly added heterologous tRNA was not effected by Sermion, ir-
respective of the age of the animals. 
In an attempt to understand the physiological relevance of the 
biochemical effects of Sermion, we have carried out some studies 
on the effect of this drug on conditioned learning in rats. The pre-
liminary data indicate that the drug is able to enhance the learning 
quotients, however, more experiments are in progress to reach a 
definitive conclusion. 
INTRODUCTION 
Observable changes in brain function often reflect disturbances of bio-
synthetic interrelationships between proteins and nucleic acids in brain cells1 • 
It is well known, for inctance, that the build-up and degradation of these 
macromolecules depend on an unimpaired cellular nutrient and oxygen supply; 
and brain functions are particularly sensitive to drugs affecting this supply2• 
For this reason we have investigated the effects of Sermion (Figure 1), a cen-
trally acting drug, on the cellular metabolism of proteins and nucleic acids in the 
* Correspondence should be sent to this author. 








Figure 1. Chemical structure of 1,6-Dimethyl-8P-(Bromoisonicotinoyl-Oxymethyl)-10ot-Methoxy-
ergoline (SERMION") . 
brain, since this drug also possesses manifest vasoactive properties3•4 and might 
be capable of modifying the supply processes. 
EXPERIMENTAL 
Materials and Methods 
L-Leucine-3H (sp. act. 5 mCi/mmol), ATP-3H (25 mCi/m~ol), S-adenosyl-L-Methio-
nine-3H-Methyl (7.2 mCi/mmol), Protosol, PPO (2,5-diphenyloxazole) and POPOP 
(2,2-p-phenylene-bis-(5-phenyl-oxazole)) were obtained from the NEN-Chemical Com-
pany, Dreieichenhain, Germany. Unlabelled substrates (UTP, ATP, CTP and GTP) 
were supplied by the Nutritional Biochem. Corp., Cleveland Ohio, U.S.A. All fine 
chemicals (p. a. -grade) were products of Merk AG, Darmstadt, Germany. 
Albino mice, weighing about 20 g, were used in our studies. The animals were 
killed by decapitation and the heads were placed in dry ice until further manipulation. 
The brains were removed, pooled (2 brains), and homogenized in an all-glass hand-
-driven homogenizer, using buffer I (0.01 M Tris, 0.0015 M MgCh, 0.01 M KCl, 
pH 7.4). Crude particles were removed by passing the homogenate through nylon tis-
sue and the filtrate was collected in a precooled centrifuge tube. The suspension was 
centrifuged at 4 °c in a Sorvall RC II at 700 X g for 20 min. The resulting sediment 
was saved for the purification of nuclei, whereas the supernatant was used directly 
for protein synthesis. The sediment was homogenized in 10 volumes of 0.01 M Tris-
-buffer, pH 7.4, containing 2.3 M sucrose and 3.3 mM CaCb, and centrifuged at 
40,000 X g for 1 h. The nuclear pellet was then suspended in 0.01 M Tris-buffer, pH 
7.4, containing 0.34 M sucrose (1 g tissue per ml) and used immediately for the in 
vitro RNA synthesis. 
Protein synthesis5 was carried out by incubating 0.3 ml portions of the 700 X g 
supernatant with 2 ~·Ci of 3H-leucine in 0.3 ml of buffer II (75 mM KCl, 10 mM MgC12, 
15 mM NaHC03, 15 mM glucose, 20 mM nicotinamide, 2.5 mM NAD, 2 mM ATP; pH 
7.4). After incubation for 30 min at 37 °c the reaction was terminated by adding 3 ml 
of 100/o trichloroacetic acid (TCA). The resulting precipitate was centrifuged, washed 
three times with 50/o TCA, and dissolved in 1 ml of protosol. The solution was mixed 
with 10 ml of toluene scintillator (4 g PPO, 100 mg POPOP; dissolved in 1 liter of 
toluene) and the radioactivity was counted in a liquid scintillation counter (Nuclear 
Chicago, Model Mark II). Protein was estimated by the method of Lowry et al. 6 
The RNA-polymerase activity of the purified nuclei was assayed in the presence 
of Mg++- or Mn++-ions7•8 •• The reaction mixture of the Mg++- activated polymerase was 
adjusted to a final volume of 0.65 ml and contained: 0.15 ml of nuclear suspension, 
50 µmol TrisHCl (pH 8.2), 5 µmol MgCh, 1 µmol of ATP (2 µCi) and 0.5 ~·mol (each) 
of CTP, UTP and GTP. The reaction mixture for Mn++/(NH4)2S04-activated poly-
merase was identical with the Mg++_containing assay medium, except that 2.2 µmol of 
MnCl2, and the pH of the system was 7.5. After equilibration at 37 °c the reaction 
was started by adding 0.15 ml of the nuclear suspension. Tl).e reaction mixture was 
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incubated for 20 min and terminated by the addition of 5 ml of cold 100/o TCA. The 
resulting precipitate was centrifuged, washed with 5Q/o TCA three times and dis-
solved in 1 ml of protosol. The protosol solution was mixed with 10 ml of toluene 
scintillation fluid, and the radioactivity was counted. DNA was estimated by the 
method of Burtono. 
tRNA-methylation in-vitro10 was carried out with the microsome-free, 150,000 x 
X g -supernatant (S-150) of mouse brain. This fraction was prepared in the following 
way: freshly removed mouse brain was homogenized with a four-fold vol. of buffer 
III (0.25 M sucrose, 10 mM MgC12 and 1 mM mercaptoethanol in 0.05 M Tris-HCl, pH 
7.8) . After 2 h centrifugation at 150,000 X g, the supernatant (S-150) was dialyzed over-
night against two changes of 1 liter each 10 mM Tris pH 7.8, 1 mM EDTA, 1 mM 
mercaptoethanol in glycerol-H20 (1 : 1) at 0-4 °c. The dialyzed material was stored 
at -20 to -3o 0c . 
The methylating system for exogenous methylation was adjusted to a final 
volume of 0.22 ml and contained : 170 pmol or E. coli- tRNA (E260 = 0.1), 20.0 ftM 
Tris-HCl pH 7.8, 2.0 µM reduced glutathione, 2.0 fLM MgC12, 0.1 µCi S-adenosyl-L-
-methionine-3H-methyl, 0.05 ml methylase fraction (0.2 mg protein), and distilled 
water to make up a total volume of 0.22 ml. After incubation for 90 min at 35 °c the 
reaction was stopped by the addition of 5 ml of 10°/o TCA. The precipitate was collected 
on a Sartorius membrane filter (diam. 25 mm, pore size 0.45 µm) and washed three 
times with ice-cold 5Q/o TCA. The filters were air dried and counted in 10 ml of 
the toluene scintillation fluid. 
The system for endogenous methylation was the same, with the exception that 
no E. coli tRNA was added to the reaction mixture. 
RESULTS AND DISCUSSION 
Quantitative changes in the synthesis of macromolecules in the brain 
under various physiological states, such as electric shock, druginduced con-
vulsions and exposure to light have been observed by several investigatorsu-15, 
(for review see ref 1). These studies were substantiated by the fact that several 
other factors like age1 and h ypophyseal hormones16 also play and important 
role in the modulation of brain protein synthesis. In recent years, the RNA and 
protein synthesizing systems of the brain have been used as »targets« to develop 
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Figure 2. In vivo effect of Ser rnion on the 3H-Leucine incorporation into cellualar mouse brain 
proteins. The drug was administered intraperitoneally , and the a nimals were decapitated at 
various posttreatment periods, as ind icated (Abscissa). The procedure is described under Expe-
rimental: 100'/o value designates an incorporation of 2340 c .p.m./mg protein, under the given 
experimental conditions. Each value is a arithmetic m ean of 4-5 different experiments. 
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The kinetics of 3H-leucine incorporation into proteins synthesized by 
700 x g supernatant of brains from differently treated animals is shown in 
Figure 2. In these experiments, albino mice were divided into three experimental 
groups of 10 each. Each of these experimental groups had its own controls with 
the same number of animals. The experimental groups received 50 µg of 
Sermion per mouse, dissolved in 0.01 M tartaric acid solution alone. The drug 
and the solvent were administered intraperitoneally. One, eight and sixteen 
hours after drug administration the animals in the three experimental. groups 
and their corresponding controls were sacrificed. The brains were removed, 
frozen in dry ice, and their capacity to synthesize proteins was measured as 
described under Materials and Methods. Each value is the arithmetic mean of 
4-5 different experiments. As shown in Figure 2, there is a significant stimul-
ation of 3H-leucine incorporation into cellular mouse brain proteins in sermion-
-treated animals. The stimulatory effect of Sermion is, however, time limited. 
Thus, a maximum stimulation of protein synthesis was seen in the first hm,ir 
of the drug administration which gradually declined with time. In these 
experiments the stimulatory response of Sermion decreased almost to the 
control level 16 h after drug treatment. 
The time course of sermion action on brain protein synthesis seems to be 
related to the metabolic degradation of the drug. The pharmacokinetic studies 
with 14C-labelled Sermion administered intraperitoneally to rats have shown 
that more than 980/o of the administered drug is excreted in the first 15 hours17. 
Even though the time factor in different studies cannot be compared, one 
cannot rule out the possibility that the metabolic fate of the drug may contribute 
to the time course of sermion action on protein synthesis as shown here. 
The effect of the drug on RNA biosynthesis under similar experimental 
treatments is shown in Figure 3. In these experiments, the capacity of a nuclear 
suspension to synthesize RNA was studied in two different systems. One 
of these systems contained Mg++-ions, whereas, the other system utilized 
Mn++-ions supplemented with ammonium sulfate. It has been reported7,s that 
the product formed in the presence of Mn++-ions and ammonium sulfate is a 
DNA-like RNA as shown by the nearest-neighbor frequency analysis and base 
composition, whereas, in the presence of Mg++-ions alone, the product formed is 
of ribosomal RNA type. 
As follows from Figure 3, the Mg++-dependent synthesis of RNA by brain 
nuclear suspensions prepared from mice 1 and 8 hours after drug treatment 
remains unchanged. The Mn+-'--dependent synthesis under similar experimental 
treatments exhibits a very small stimulatory effect of Sermion at 1 hour, but 
no effect after 8 hours of drug treatment. Since the specific deviation in the 
experiments was ± 10-12°/(), the stimulatory effect observed at 1 h post-
-treatment may not be significant. 
The above in-vitro data transposed to the in-vivo situation would mean 
that Sermion has no effect on the synthesis of ribosomal-like RNA, whereas it 
may have a slight stimulatory effect on the synthesis of messenger-like RNA 
in the early phase of its action. However, due to a very high complexity of 
polymorphic structure and a high turn-over rate of macromolecules in the 
brain, this interpretation may, or may not, be valid. The increase of protein 
synthesis observed in short time intervals after Sermion treatment could be 
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Figure .3. In-vivo effect of Sermion on the biosynthesis of RNA, catalyzed by Mg++-ions, or 
Mn++-ions supplemented with ammonium sulfate. Experimental details as described in the text 
and under Experimental: 100'/o incorporation designates 4085 c.p.m./mg of nuclear DNA. Eeach 
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Figure 4. In-vivo effect of Sermion on the endogenenous m ethylation of proteins and tRNA from 
mouse brain: S1 and S2 a r e the enzyme p reparations f rom Sermion-treated animals (S1 = 1 h 
post-treatment period; S2 = 2 h post-treatment period). TC1 and TC2 are the enzyme preparations 
from control animals treated with the solvent (TC1 = 1 h post-treatment; TC2 = 2 h post-treat-· 
ment). Abscisa = incubation time i nmin.; ordinate= percent incorporation of 'H-methyl groups 
over controls. All values were calculated as c .p .m ,/mg of protein present in the enzyme fraction. 
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protection and stabilization of polysomal structures and posttranscriptional 
modification of RNA and proteins. 
Differences in activity of brain tRNA methylases have been reported as a 
function of topographical region18, developmental stage19, age20 , and tumori-
genesis21. Using dialyzed crude brain extract, Kaplan et al.22 have studied the 
tRNA methylase activity in fish brain after behavioral training. These authors 
failed to detect any quantitative differences in the total methylase activity as 
a function of training. 
The effect of Sermion on the endogenous methylation of tRNA and pro-
teins, one and two hours after i. p. -administration of the drug is shown in Fi-
gure 4. Tre curves depict the· percent stimulation of enzyme activities at one 
hour (S1 ) and two hours (S2) post-drug treatment, compared to controls, treated 
with tartaric acid alone (Tc1 and Tc2). Under these conditions we found an 
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Figure 5. Methylation of exogenously added tRNA by brain preparations from mice of dif-
ferent age groups : methyltransferases were isolated from mice weighing 5g, lOg and · 20g. The 
experimental details are described under Experimental. 
0-0 ~ methyltransferase (5g); •-• ~ methyltransferase (lOg); 6.- 6. ~ methyltransferase (20g) 
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1 hour post-treatment; however, the stimulatory effect was not significant 
after 2 hours of drug treatment. The stimulatory effect was evident at 25 and 
125 minutes of incubation. 
In another set of experiments the kinetics of methylation at various tRNA 
concentrations were studied in brain preparations from mice of different age 
groups. For these experiments, mice were divided by weight into three groups; 
methyl transferases were isolated from mice weighing 5 g, 10 g and 20 g. As 
follows from Figure 5, the ability of mouse brain preparations to catalyze 
the methyl group incorporation into tRNA decreases as the age of the animals 
increases. Using a dialyzed 160,000 x g supernatant, Johnson et al.20 have 
recently studied the tRNA methylase activity in neonatal and mature mouse 
brains. When increasing amounts of the dialyzed supernatants from young 
and adult mouse brain were added to reaction mixtures, the saturation kinetics 
was found to be considerably different; at concentrations above 50 µg protein, 
the methylase activity of brain preparations from adult mice reached a plateau, 
whereas the methylase activity of neonatal brain preparations showed a linear 
rise. In all these experiments the endogenous values for each group of animals 
were subtracted; the endogenous value for 5 g mice was 930 c.p.m/mg protein; 
for 10 g mice 714 c.p.m/mg protein; and for 20 g mice 677 c.p.m/mg protein. 
The in-vitro effects of Sermion on the endogenous mehylation by brain 
preparations from mice of different age groups (5 g, 10 g and 20 g body weigh) 
is shown in Figure 6. As follows from Figure 6, Sermion at 10-4 M stimulates 
the endogenous methylation of tRNA and proteins, in brain preparations from 
mice of all age groups. However it is remarkable that the stimulating effec1 
of sermion in brain preparations from older animals (lOg and 20 g body 
weight) is higher than that observed in the 5 g animals. Under similar experi-
mental conditions we failed to observe any effect of sermion (10-4 M) on the 
methylation of exogenously added tRNA by brain preparations from mice of 
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Figure 6. In-vitro effect of Sermion on the endogeneous methylation of brain preparations from 
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Figure 7. In-vitro effect of sermion c10-• M) on the methylation of exogenously added tRNA by 
brain preparations from mice of various groups. For experimental details see Experimental. 
portion of the endogenous methylation in rat brain cortex involves homologous 
tRNA. It remains to be investigated whether the endogenous methylation in 
various age groups is entirely due to homologous tRNA, or are proteins also 
involved. The pattern of methylation of RNA in the peripheral nerve of the 
chick during development has been studied by Mezei and Hu24 • According 
to their observations the incorporation of methyl groups from methionine was 
the highest in the heavy RNA species of the 14-day embryonic nerve. In 
contrast, in the nerves of 3-day-old chicks, methylation was entirely localized 
to tRNA species. The situation in our experiments is different, since no heavy 
RNA fraction was present in the supernatants (150,000 x g) used by us. 
The in vivo and in-vitro effects of Sermion on the methylation of endo-
genous tRNA and proteins are similar, in the sense that both are stimulated. 
The inability of Sermion to stimulate the methylation of exogenously added 
tRNA is, at present, unexplained. Experiments are ·in progress to verify these 
effects using methyl transferases, purified by column chromatography. 
In an attempt to understand the neurobiological relevancei of the bio-
chemical effects of Sermion, we have carried out some preliminary studies 
on the effect of this drug on conditioned learning in rats. For these studies a 
training cage for rats was devised and employed to measure the physiological 
response of learning. By pressing a training lewer at 10 second intervals, 
it was possible for the rat to receive a food pellet reward·. The number of food 
pellets each rat received in a constant period of time was recorded automa-
tically. This number divided by the maximum number of pellets possible to 
receive (theoretical number) yields the quotient of success of each individuals 
test. The rats were fasted 16 h before the training was programmed. 
The effect of Sermion (10 mg/kg, i. p .) on the learning tests of rats (150 
g body weight, all males, Sprague-Dawley) is shown in Table I. The values 
indicate the percent of success (quotient X 100) in the different groups. 
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TABLE I 
Effect of Sermion on the Percent Success of Rats Subsjected to Conditioned Learning 
Treatment/I mg/100 g Time after success"/O/o (kind of injected drug) injection/h 
NaCl 1 64.9 
24 65 
Tartaric acid 1 72.7 
24 66.7 
Sermion 1 53.7 
2 92 
24 83.4 
• Success : number of pellets rat received in the training cage, divided by the number of pellets 
possible to receive (theoretical number) . 
As follows from Table I , the animals of the control group treated with 
NaCl and tartaric acid solutions (2 animals each) showed a quotient of 65-720/o_ 
The animals treated with Sermion exhibited a variable quotient, depending 
upon the post treatment period. One hour after the drug treatm!=nt the quotient 
was lower than in the controls, however, at 2 and 24 h post-treatment the 
quotients were significantly higher. We observed that the animals in the 1st 
hour :;i.fter drug treatment were »very tired«, which could have been due to 
the hypotensive effect of the drug at this dose. This might explain the low 
quotient at 1 h. 
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SAZETAK 
Djelovanje 1,6-dimetil-8~-(bromizonikotinoil-oksimetil)-lOa-metoksiergolina 
(Sermionn) na neke molekularne procese u mozgu 
B. Mildner, A . Paul i P. Chandra 
Studirano je djelovanje SermionaR na celularnu sintezu proteina u mozgu m1sa 
in vivo, nakon intraperitonealne primjene doza od 50 ~tg . Uzorci mozga ispitani u 
razlicitim vremenskim razmacima nakon primjene Sermionaa pokazali su kratkotraj_no 
povecanje ugradnje 3H-leucina u proteine, nakon cega se ugradnja normalizirala, do-
segavsi kontrolne vrijednosti nakon 18 sati. Pod slicnim uvjetima SermionR nije 
pokazao utjecaj na sintezu RNA kataliziranu ionima Mg2+ ,ali je opazeno blago stimu-
liranje sinteze RNA aktivirane s pomocu Mn2+. 
Misevi koji su primili intraperitonealne injekcije od 50 µg Sermiorian pokazali 
SU povecanu aktivnost metiltransferaze, a maksimalna je aktivnost bila dosegnuta 
1 sat nakon primjene. U zasebnom nizu eksperimenata pokazalo se da sposobnost 
preparata mozga misa za ugradnju metilne skupine u tRNA dodanu izvana opada sa 
staroscu zivotinje. Dodatak 10-4 M Sermiona inkubacijskom mediju pojacao je endo-
geno metiliranje, posebno u starijih zivotinja. Nasuprot tomu, Sermionn nije u t jecao 
na sposobnost metiliranja izvana dodane tRNA ,bez obzira na dob zivotinje. 
U pokusaju da se r azumije fiziolosko znacenje biokemijskog efekta Sermiona\ 
proucavano je njegovo djelovanje na uvjetno ucenje u stakora. Preliminarni podaci 
ukazuju da taj spoj povecava kvocijent ucenja, no tek daljnji eksperimenti pokazat 
ce ispravnost toga zakljucka. 
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